About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
General Archive
Home
»
Phase I
TIARA: Autologous Tregs for Aplastic Anaemia
Read more
Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type II
Read more
Close Modal
